Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to determine if intravenous tranexamic acid (TXA) is
effective for reducing blood loss during high risk surgical procedures related to placenta
previa and placenta accreta. TXA is currently used in other types of surgery for patients who
are expected to have a large blood loss, such as orthopedic or open heart surgery.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Central California Faculty Medical Group University of California, San Francisco Fresno